Showing results (71-80 of 510) with videos related to
Sort By:
Pageof 51
Expert Review of Clinical Immunology|December 10, 2015
Soluble molecules in intravenous immunoglobulin: benefits and limitationsMaryam Azimi, Asghar Aghamohammadi, Hans D Ochs, et al.Expert Review of Clinical Immunology|May 21, 2011
Indications and safety of intravenous and subcutaneous immunoglobulin therapyNima Rezaei, Hassan Abolhassani, Asghar Aghamohammadi, et al.The Journal of Allergy and Clinical Immunology|April 2, 2013
Controversies in IgG replacement therapy in patients with antibody deficiency diseasesErwin W Gelfand, Hans D Ochs, William T ShearerTherapeutics and Clinical Risk Management|February 20, 2010
Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency diseaseSuzanne Skoda-Smith, Troy R Torgerson, Hans D OchsCytoskeleton (Hoboken, N.J.)|July 15, 2011
Lentivectors are efficient tools to manipulate the dendritic cell cytoskeletonJoao Metelo, Natalie Ward, Adrian J Thrasher, et al.Blood|August 17, 2004
Mechanisms of WASp-mediated hematologic and immunologic diseaseSiobhan Burns, Giles O Cory, William Vainchenker, et al.Stem Cells and Cloning : Advances and Applications|November 8, 2013
Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiencyClaudia A Montiel-Equihua, Adrian J Thrasher, H Bobby GasparImmunological Reviews|October 15, 2013
Actin cytoskeletal defects in immunodeficiencyDale A Moulding, Julien Record, Dessislava Malinova, et al.British Journal of Haematology|March 14, 2019
How I manage patients with Wiskott Aldrich syndromeElizabeth Rivers, Austen Worth, Adrian J Thrasher, et al.Human Molecular Genetics|July 13, 2019
Gene therapy for primary immunodeficiencyClaire Booth, Rosa Romano, Maria Grazia Roncarolo, et al.Pageof 51